Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-12-08Clinical Trial Update: Study of INCB053914 in Subjects With Advanced Malignancies [Phase 1, Phase 2]
A Phase 1/2 trial of INCB053914 in subjects with advanced solid tumors has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2021-12-06Clinical Trial Update: The Safety, Pharmacokinetics and Antitumor Activity of BGB-A317 in Combination With BGB-290 in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 trial assessing safety, pharmacokinetics, and antitumor activity of BGB-A317 in combination with BGB-290 in advanced solid tumors; r…
-
CLINICAL_TRIALS trial_result · 2021-11-24Clinical Trial Update: A Study of LY3499446 in Participants With Advanced Solid Tumors With KRAS G12C Mutation [Phase 1, Phase 2]
Phase 1/2 trial of LY3499446 in advanced solid tumors with KRAS G12C has been terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-11-23Clinical Trial Update: Study to Assess MEDI4736 With Either AZD9150 or AZD5069 in Advanced Solid Tumors & Relapsed Metastatic Squamous Cell Carcinoma of Head & Neck [Phase 1, Phase 2]
A Phase 1/2 clinical trial update reports results for durvalumab (MEDI4736) in combination with AZD9150 or AZD5069 in patients with advanced…
-
CLINICAL_TRIALS trial_result · 2021-11-22Clinical Trial Update: Clinical Trial of Lurbinectedin (PM01183) in Selected Advanced Solid Tumors [Phase 2]
Phase 2 clinical trial update for lurbinectedin (PM01183) in selected advanced solid tumors has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-11-18Clinical Trial Update: Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating vorinostat in combination with etoposide in pediatric patients under 21 with refractory solid tumors, co…
-
CLINICAL_TRIALS trial_result · 2021-11-17Clinical Trial Update: Safety, Dose Tolerance, Pharmacokinetics, and Pharmacodynamics Study of CPX-POM in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 trial update evaluating safety, dose tolerance, pharmacokinetics, and pharmacodynamics of CPX-POM in patients with advanced solid tu…
-
CLINICAL_TRIALS trial_result · 2021-11-09Clinical Trial Update: A Study of Niraparib as Single Agent in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 trial evaluating niraparib as a single agent in participants with advanced solid tumors has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-10-28Clinical Trial Update: Phase 1/2 Study of Derazantinib (ARQ 087) in Adult Subjects With Advanced Solid Tumors With FGFR Genetic Alterations [Phase 1, Phase 2]
Phase 1/2 study of derazantinib (ARQ 087) in adults with advanced solid tumors carrying FGFR genetic alterations has completed with posted r…
-
CLINICAL_TRIALS trial_result · 2021-10-12Clinical Trial Update: Sym023 (Anti-TIM-3) in Patients With Advanced Solid Tumor Malignancies or Lymphomas [Phase 1]
Phase 1 trial update for Sym023 (anti-TIM-3) in patients with advanced solid tumors, metastatic cancer, or lymphomas; results posted after c…
-
CLINICAL_TRIALS trial_result · 2021-10-11Clinical Trial Update: Phase 1/2a Study of BAL101553 as 48-hour Infusions in Patients With Advanced Solid Tumors or Recurrent Glioblastoma [Phase 1, Phase 2]
Phase 1/2a study of BAL101553 given as 48-hour infusions in adults with advanced solid tumors or recurrent glioblastoma has completed testin…
-
CLINICAL_TRIALS trial_result · 2021-10-06Clinical Trial Update: Phase 1/2 Study of X-396, an Oral ALK Inhibitor, in Patients With ALK-positive Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 study of X-396 (an oral ALK inhibitor) in ALK-positive non-small cell lung cancer and other advanced solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2021-09-28Clinical Trial Update: MEN1309 I.v. Infusion in Pts With CD205-positive Metastatic Solid Tumors and Relapsed or Refractory NHL Ph I Study [Phase 1]
Phase 1 study update for MEN1309 intravenous infusion in CD205-positive metastatic solid tumors and relapsed/refractory non-Hodgkin lymphoma…
-
CLINICAL_TRIALS trial_result · 2021-09-27Clinical Trial Update: Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-Pamiparib in Participants With Advanced Cancer [Phase 1]
Phase 1 study evaluating absorption, metabolism, and excretion of radiolabeled pamiparib in participants with advanced cancer completed; res…
-
CLINICAL_TRIALS trial_result · 2021-08-13Clinical Trial Update: A Phase 1/2 Study of TY101 for Locally Advanced /Metastatic Solid Tumors and Relapsed or Refractory Lymphomas [Phase 1, Phase 2]
This is a Phase 1/2 clinical trial update for TY101 evaluating safety and efficacy in locally advanced/metastatic solid tumors and relapsed …
-
CLINICAL_TRIALS trial_result · 2021-08-10Clinical Trial Update: Testing AZD5363 as a Potential Targeted Treatment in Cancers With AKT Genetic Changes (MATCH-Subprotocol Y) [Phase 2]
A Phase 2 MATCH subprotocol evaluating AZD5363 (capivasertib) for cancers with AKT genetic alterations; the study is marked as active but no…
-
CLINICAL_TRIALS trial_result · 2021-07-28Clinical Trial Update: A Phase I Study of Zalypsis (PM00104) in Subjects With Advanced Malignant Solid Tumors or Lymphoma [Phase 1]
Phase I study of Zalypsis (PM00104) in advanced malignant solid tumors or lymphoma; the trial status is terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2021-07-26Clinical Trial Update: AZD1775 for Advanced Solid Tumors [Phase 1]
Phase 1 trial update for AZD1775 in advanced solid tumors has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-07-23Clinical Trial Update: Phase 1/2 Study of USL311 +/- Lomustine in Advanced Solid Tumors or Relapsed/Recurrent Glioblastoma Multiforme (GBM) [Phase 1, Phase 2]
Phase 1/2 trial of USL311 +/- lomustine in advanced solid tumors and relapsed/recurrent glioblastoma multiforme (GBM) was terminated with re…
-
CLINICAL_TRIALS trial_result · 2021-07-20Clinical Trial Update: Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II) [Phase 1, Phase 2]
Phase I/II trial evaluating CBP501 in combination with pemetrexed and cisplatin for malignant pleural mesothelioma; study completed with pos…
-
CLINICAL_TRIALS trial_result · 2021-06-24Clinical Trial Update: Microtransplantation for Advanced and Relapsed Solid Tumors [Phase 1, Phase 2]
A clinical trial update on microtransplantation for advanced and relapsed solid tumors across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2021-06-23Clinical Trial Update: Study of DS-8201a in Subjects With Advanced Solid Malignant Tumors [Phase 1]
Phase 1 study of DS-8201a in subjects with advanced solid malignant tumors has completed enrollment with results posted.
-
CLINICAL_TRIALS trial_result · 2021-06-14Clinical Trial Update: NKTR-102 in Combination With Cetuximab in Patients With Refractory Solid Tumors (Phase 2a) and Metastatic or Locally Advanced Colorectal Cancer (Phase 2b) [Phase 2]
Phase 2 study results for NKTR-102 in combination with cetuximab in refractory solid tumors and metastatic/locally advanced colorectal cance…
-
CLINICAL_TRIALS trial_result · 2021-06-08Clinical Trial Update: A Study of E7050 in Combination With E7080 in Participants With Advanced Solid Tumors (Dose Escalation) and in Participants With Recurrent Glioblastoma or Unresectable Stage III or Stage IV Melanoma After Prior Systemic Therapy (Expansion Cohort and Phase 2) [Phase 1, Phase 2]
A phase 1/2 study of E7050 in combination with E7080 in advanced solid tumors and specific recurrent/unresectable cancers; the trial status …
-
CLINICAL_TRIALS trial_result · 2021-06-04Clinical Trial Update: A Study of Atezolizumab in Advanced Solid Tumors [Phase 2]
Phase 2 trial update of atezolizumab in advanced solid tumors with results posted.